Neuronal PPP2R5C in plasma is a potential biomarker for early diagnosis of Alzheimer’s disease

Key Result

Neuronal PPP2R5C detected in plasma shows potential as a biomarker for early diagnosis of Alzheimer's disease.

Key Points

• The aim is to evaluate the role of neuronal PPP2R5C in plasma as an early biomarker for Alzheimer’s disease.
• Analysis of plasma levels of PPP2R5C in individuals with early-stage Alzheimer's disease.
• Comparative evaluation with control subjects.
• Statistical correlation of PPP2R5C levels with cognitive decline indicators.
• Higher levels of PPP2R5C were detected in participants with early Alzheimer's compared to controls.
• The presence of PPP2R5C correlated significantly with cognitive impairment scores.
• Identifying PPP2R5C as a potential early diagnostic marker for Alzheimer's disease.